Status:
COMPLETED
Interobserver Variability Desmoplasia
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Cutaneous Squamous Cell Carcinoma
Pathology
Eligibility:
All Genders
16+ years
Brief Summary
According to the most recent guideline of the National Comprehensive Cancer Network (NCCN), desmoplasia is considered to be a very high risk factor for recurrence, metastasis and death in cutaneous sq...
Eligibility Criteria
Inclusion
- Histological coupes of patients with a cSCC between 2010 and 2018 (both cSCC with and without desmoplasia are included)
- Treated at the Maastricht University Medical Center+ (MUMC+)in Maastricht for their cSCC
- Of which the histology is available in the MUMC+
Exclusion
- \- None
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06020612
Start Date
July 1 2023
End Date
June 1 2024
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center+
Maastricht, Netherlands